AllianceBernstein’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.6M Sell
380,448
-7,945
-2% -$1.98M 0.03% 415
2025
Q4
$93.6M Buy
388,393
+20,461
+6% +$5.23M 0.03% 426
2025
Q3
$101M Buy
367,932
+81,854
+29% +$22.4M 0.03% 399
2025
Q2
$73.8M Buy
286,078
+55,790
+24% +$13.3M 0.02% 495
2025
Q1
$51.5M Sell
230,288
-110,645
-32% -$25.8M 0.02% 579
2024
Q4
$78M Sell
340,933
-60,454
-15% -$14.6M 0.03% 472
2024
Q3
$98M Buy
401,387
+37,925
+10% +$8.47M 0.03% 414
2024
Q2
$69.6M Buy
363,462
+6,206
+2% +$1.26M 0.02% 508
2024
Q1
$70.7M Sell
357,256
-7,422
-2% -$1.36M 0.03% 508
2023
Q4
$62.7M Buy
364,678
+180,531
+98% +$27.7M 0.02% 524
2023
Q3
$27.2M Sell
184,147
-31,648
-15% -$5.72M 0.01% 748
2023
Q2
$47.2M Buy
215,795
+12,059
+6% +$2.69M 0.02% 592
2023
Q1
$44.6M Sell
203,736
-17,124
-8% -$3.72M 0.02% 597
2022
Q4
$46M Buy
220,860
+29,039
+15% +$6.38M 0.02% 606
2022
Q3
$41.9M Buy
191,821
+583
+0.3% +$133K 0.02% 590
2022
Q2
$40.1M Sell
191,238
-35,257
-16% -$7.51M 0.02% 631
2022
Q1
$54.9M Buy
226,495
+8,052
+4% +$1.95M 0.02% 573
2021
Q4
$56.9M Buy
218,443
+13,709
+7% +$3.56M 0.02% 583
2021
Q3
$54M Buy
204,734
+3,745
+2% +$1.02M 0.02% 594
2021
Q2
$49.5M Sell
200,989
-10,565
-5% -$2.22M 0.02% 623
2021
Q1
$41M Sell
211,554
-8,172
-4% -$1.64M 0.02% 670
2020
Q4
$46.7M Sell
219,726
-9,591
-4% -$1.91M 0.02% 606
2020
Q3
$39.3M Buy
229,317
+2,340
+1% +$432K 0.02% 607
2020
Q2
$43.6M Sell
226,977
-10,414
-4% -$1.7M 0.03% 549
2020
Q1
$35M Sell
237,391
-3,688
-2% -$587K 0.03% 539
2019
Q4
$37.4M Sell
241,079
-6,131
-2% -$884K 0.02% 623
2019
Q3
$33.4M Sell
247,210
-1,368
-0.6% -$179K 0.02% 633
2019
Q2
$30.3M Sell
248,578
-10,796
-4% -$1.2M 0.02% 679
2019
Q1
$27M Sell
259,374
-3,680
-1% -$380K 0.02% 715
2018
Q4
$30M Buy
263,054
+6,610
+3% +$708K 0.02% 634
2018
Q3
$29.6M Sell
256,444
-1,845
-0.7% -$202K 0.02% 673
2018
Q2
$26.8M Buy
258,289
+20,183
+8% +$2.04M 0.02% 705
2018
Q1
$23.4M Sell
238,106
-11,750
-5% -$1.11M 0.02% 721
2017
Q4
$21.2M Sell
249,856
-4,647
-2% -$384K 0.02% 762
2017
Q3
$19.6M Buy
254,503
+138,271
+119% +$10.6M 0.01% 781
2017
Q2
$9.05M Buy
116,232
+3,828
+3% +$274K 0.01% 959
2017
Q1
$8.09M Buy
112,404
+450
+0.4% +$31.1K 0.01% 994
2016
Q4
$6.95M Buy
111,954
+10,314
+10% +$632K 0.01% 1034
2016
Q3
$6.58M Sell
101,640
-2,155
-2% -$143K 0.01% 1008
2016
Q2
$6.56M Buy
103,795
+340
+0.3% +$20K 0.01% 963
2016
Q1
$5.98M Sell
103,455
-1,943
-2% -$110K 0.01% 986
2015
Q4
$5.66M Sell
105,398
-2,268
-2% -$128K ﹤0.01% 1013
2015
Q3
$5.49M Sell
107,666
-9
-0% -$484 ﹤0.01% 1020
2015
Q2
$6.07M Sell
107,675
-8,056
-7% -$508K 0.01% 1044
2015
Q1
$8.31M Sell
115,731
-7,019
-6% -$456K 0.01% 947
2014
Q4
$6.88M Sell
122,750
-1,225
-1% -$64K 0.01% 999
2014
Q3
$6.11M Buy
123,975
+1,910
+2% +$97.3K 0.01% 1019
2014
Q2
$6.18M Sell
122,065
-7,271
-6% -$360K 0.01% 1031
2014
Q1
$5.78M Sell
129,336
-400
-0.3% -$18K 0.01% 1063
2013
Q4
$6.11M Sell
129,736
-1,931
-1% -$97.7K 0.01% 1021
2013
Q3
$6.96M Sell
131,667
-7,444
-5% -$361K 0.01% 939
2013
Q2
$6.28M Buy
+139,111
New +$6.6M 0.01% 916

Other funds holding RMD

AllianceBernstein's RMD Position: Q1 2026 in Review

AllianceBernstein reduced its ResMed (RMD) stake by 2% in Q1 2026, selling an estimated $1.98M and leaving 380,448 shares worth $91.6M. The position accounts for 0.03% of the portfolio, ranked #415.

AllianceBernstein first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • AllianceBernstein held 380,448 shares of ResMed worth $91.6M as of Q1 2026.
  • AllianceBernstein sold 7,945 ResMed shares in Q1 2026, an estimated $1.98M.
  • ResMed made up 0.03% of AllianceBernstein's portfolio in Q1 2026, its #415 holding.
  • AllianceBernstein first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's ResMed position peaked at $101M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.